Development of new therapy for children suffering from Epidermolysis Bullosa [ 2012 - 2015 ]

Also known as: Development of new therapy for children suffering from skin blistering diseases

Research Grant

[Cite as]

Researchers: Dr Zlatko Kopecki (Principal investigator)

Brief description Skin blistering diseases affect 1:17,000 live births. Constant skin blistering affects the quality of life and is often fatal in the first 2 years. For those children that survive, skin blistering leads to scarring, fusion of the fingers, infections and skin cancers. To date, the management of blistered children is mainly supportive and no specific cure exists. This study will develop new therapies for children with skin blistering diseases and will significantly improve their quality of life.

Funding Amount $AUD 307,946.17

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]